Blog - Page 3270 of 5749

FridayMay 11, 2012 3:54 pm

Cardium Therapeutics, Inc. (CXM) Growing Footprint in Health Sciences and Regenerative Medicine Space

Cardium Therapeutics has built a name for itself by capturing innovative biomedical technologies that emerge in the health sciences and regenerative medicine space, while simultaneously developing its own technology portfolio. By focusing on underserved demand and products/business opportunities with a clear path to monetization, CXM has been able to create a lightweight approach that harnesses all of the external partner, market, and technology strengths, while avoiding the cost structure pitfalls that plague many other operators in the same sector. The envelope of medical business opportunities CXM has assembled to date includes the in-house MedPodium® Health Sciences healthy lifestyle product platform,…

FridayMay 11, 2012 3:29 pm

CytoSorbents Corp. (CTSO) CEO Named as Finalist for Ernst & Young Entrepreneur of the Year 2012

CytoSorbents, a critical care-focused company using blood purification to modulate the immune system and fight multi-organ failure in life-threatening illnesses, today announced its CEO, Dr. Phillip Chan, was named as a finalist in the Ernst & Young Entrepreneur Of The Year® 2012 program, which recognizes entrepreneurs with demonstrated success in areas such as innovation, financial performance, and personal commitment. Dr. Chan was selected by an independent judging panel comprised of previous winners, CEOs, private capital investors, and other regional business leaders. Since his appointment as CytoSorbents CEO and president in 2009, Dr. Chan has taken initiatives to build the company…

FridayMay 11, 2012 3:24 pm

European Medicines Agency Awards Arno Therapeutics, Inc. (ARNI) AR-42 Orphan Drug Designation

Arno Therapeutics, a clinical-stage company focused on developing products for the treatment of cancer, today announced that its investigational compound AR-42 has been granted orphan-drug designation by the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products for the treatment of neurofibromatosis type 2 (NF2), a rare genetic disorder characterized by the growth of noncancerous tumors in the brain and spinal cord, juvenile cataracts, and neurofibromas of the skin. The EMA grants orphan-drug designation for medicines designed to treat life-threatening or debilitating conditions affecting no more than five in 10,000 people, and allows the developer to obtain inspection-fee reductions, protocol…

FridayMay 11, 2012 12:49 pm

American Energy Development Corp. (AEDC) Gives Drilling Update on Project in Michigan

American Energy Development is an independent oil and gas company seeking to expand through the development of acreage in established oil and gas basins. The company's current focus is on development of acreage in the Niagaran oil reefs in Michigan and in underexplored onshore basins in the United Kingdom. The Niagaran Reef is of particular interest to the company. Historical records of the Niagaran reef production in Michigan confirm more than 4,200 wells have been drilled targeting reef formations. Much of the drilling in the region has been conducted by major players in the energy industry, including Royal Dutch Shell,…

FridayMay 11, 2012 12:39 pm

SilverSun Technologies, Inc. (SSNT) and the Internal Turnaround

When one thinks of company turnarounds, it’s normal to imagine outside investors bringing in their own people, restructuring everything, perhaps chopping off various company operations, or even pointing the company to a brand new market. More common, however, is the internal turnaround, sometimes led by a new CEO, but often simply initiated by a transition in thinking within the existing executive team. Some attempts are successful, others are not. Indeed it is said that the quality of a company is best measured by how they respond to difficult times. Such is the case with SilverSun Technologies, a nationwide small business…

FridayMay 11, 2012 10:11 am

Victory Energy Corp. (VYEY) Makes Major Progress, Sets 2012 Goals

Victory Energy is a domestic energy company engaged in the production of oil and natural gas through its onshore wells in west Texas, Oklahoma, and New Mexico. Currently, the company has 17 wells in production with the capacity to expand to an additional 31 wells. VYEY seeks to maximize shareholder value over the long term by increasing accessible oil reserves, producing more oil, lowering its costs, and carefully managing the capital entrusted to it. For 2012, the company looks to invest in acreage with proved reserves in order to minimize its exploration and development costs. To gauge how the company…

FridayMay 11, 2012 9:51 am

Beacon Equity Research Featured Company: Breezer Ventures, Inc. (BRZV)

Breezer Ventures is a publicly traded emerging natural resources company focused on oil and gas acquisition, exploration, and production. The company is also engaged in the acquisition, production, exploration, and development of natural gas and minerals. Breezer specializes in sustainable, low-cost oil and gas production that delivers value from efficiency. The company currently owns and operates Well #6 in the Jackson oil and gas leases in Texas. The Jackson Lease presently contains 870 acres situated 5 miles north of Baird, Texas, on the western side of the Bend Arch of the Fort Worth Basin. Currently, there are 10 existing and…

FridayMay 11, 2012 9:48 am

StockGuru Featured Company: Strategic Global Investments, Inc. (STBV)

Strategic Global Investments, a publicly traded Delaware corporation, is a diversified company with ventures in online media, digital advertising, social media, and emerging technologies. The company also owns resort property in the Los Cabos area of Baja, Mexico, which provides a substantial asset base and offers significant future income potential. Through its Web sites and social media, Strategic Global Investments provides live streaming video content and related digital advertising. Its online business consists of two segments, WaZillo and WaZillo Media. WaZillo’s online network of live streaming video connects users with destination venues, enabling them to assess places of interest and…

FridayMay 11, 2012 9:36 am

iPass, Inc. (IPAS) Expands European Channel Partner Program

iPass announced that it has expanded its European channel partner program to target mobile device management (MDM) market adjacencies. Through these initiatives, the global Wi-Fi service and enterprise mobility leader aims to recruit new MDM channel partner experts, which will assist them in capitalizing on the growth of remote working and consumerisation of IT. Partners with MDM expertise can now complement their existing mobility solutions with iPass’ Open Mobile platform. The platform provides access to the world's largest commercial Wi-Fi network with over 800,000 hotspots in 118 countries. With the simplified iPass channel program, customers can gain a competitive edge…

FridayMay 11, 2012 9:21 am

Obscene Jeans Corp. (OBJE) Subsidiary Signs Deal to Develop Games

Yesterday, Obscene Interactive, a subsidiary of Obscene Jeans Corp., announced that it has signed a deal to develop electronic games in-house that would span multiple platforms such as iOS, Android, and Facebook. These games will focus on utilizing a Free To Play (FTP) model, in which games are free for users but facilitate microtransactions within the game. Obscene Interactive is focused on producing social gaming applications, with a technology platform that allows the company's titles to be accessed by users globally and across multiple OS platforms. Obscene's strategy is utilizing the viral nature of social platforms like Facebook to reach…

Site Search

Company Search